Ma ʻApelila 30, 2019, ua hoʻokuʻu ka US Food and Drug Administration (FDA) i kahi hōʻike e pili ana kekahi mau lapaʻau maʻamau no ka insomnia ma muli o nā ʻano moe paʻakikī (me ka hiamoe hiamoe, ka hoʻokele hiamoe, a me nā hana ʻē aʻe ʻaʻole i ala pono).Ua loaʻa mai kahi ʻeha kakaʻikahi akā koʻikoʻi a i ʻole ka make.ʻOi aku ka maʻamau o kēia mau ʻano i ka eszopiclone, zaleplon, a me zolpidem ma mua o nā lāʻau lapaʻau ʻē aʻe i hoʻohana ʻia e mālama i ka insomnia.No laila, koi ka FDA i nā ʻōlelo aʻo pahu ʻeleʻele i kēia mau ʻōlelo aʻoaʻo lāʻau lapaʻau a me nā alakaʻi lāʻau lapaʻau maʻi, a me ka koi ʻana i nā maʻi i ʻike mua i ke ʻano moe maʻamau me ka eszopiclone, zaleplon, a me zolpidem ma ke ʻano kapu..
ʻO Eszopiclone, zaleplon, a me zolpidem nā lāʻau hoʻomaha a me ka hypnotic i hoʻohana ʻia no ka mālama ʻana i nā maʻi hiamoe makua a ua ʻae ʻia no nā makahiki he nui.Loaʻa nā ʻeha nui a me nā make ma muli o ka moe hiamoe paʻakikī i nā poʻe maʻi me ka moʻolelo o ka ʻano like ʻole, inā e hoʻohana ana i ka maʻi haʻahaʻa haʻahaʻa i ʻōlelo ʻia a i ʻole hoʻokahi maʻa, me ka waiʻona a i ʻole nā mea hoʻopaneʻe ʻē aʻe o ke kikowaena pūnaewele (e laʻa, nā mea hoʻomaha, opioids) hiamoe maʻamau. Hiki ke hana me kēia mau lāʻau lapaʻau, e like me nā lāʻau lapaʻau, a me nā lāʻau anti-anxiety.
No ka ʻike o nā limahana lapaʻau:
ʻO ka poʻe maʻi me ka moe hiamoe paʻakikī ma hope o ka lawe ʻana i ka eszopiclone, zaleplon, a me zolpidem e pale i kēia mau lāʻau;inā he paʻakikī ko ka poʻe maʻi i ka moe hiamoe, pono lākou e hoʻōki i ka hoʻohana ʻana i kēia mau lāʻau no kēia mau lāʻau.ʻOiai kakaʻikahi, ua hōʻeha nui a make paha.
No ka ʻike maʻi:
Inā ʻaʻole i ala pono ka mea maʻi ma hope o ka lawe ʻana i ka lāʻau lapaʻau, a inā ʻaʻole ʻoe e hoʻomanaʻo i nā hana āu i hana ai, ua paʻakikī paha ʻoe i ka moe hiamoe.E kāpae i ka hoʻohana ʻana i ka lāʻau no ka insomnia a e ʻimi koke i ka ʻōlelo aʻoaʻo olakino.
I loko o nā makahiki he 26 i hala iho nei, ua hōʻike ka FDA i 66 mau hihia o nā lāʻau e hoʻoulu ai i nā ʻano moe paʻakikī, aia wale nō mai ka FDA's Adverse Event Reporting System (FEARS) a i ʻole nā palapala lāʻau lapaʻau, no laila ua nui aʻe nā hihia i ʻike ʻole ʻia.ʻO 66 mau hihia i loaʻa i ka overdose pōʻino, hāʻule, kuni, make, ʻike i ka hana o nā lālā i nā wela haʻahaʻa loa, ka make ʻana o carbon monoxide, ka make ʻana, hypothermia, nā hui kaʻa kaʻa, a me ka hōʻeha iā ia iho (e laʻa i nā ʻeha pū a me ka hoʻāʻo ʻana i ke ola kino).ʻAʻole hoʻomanaʻo pinepine nā maʻi i kēia mau hanana.ʻAʻole maopopo i kēia manawa nā ʻano kumu kumu e hoʻoulu ai kēia mau lāʻau insomnia i ka moe moe paʻakikī.
Ua hoʻomanaʻo pū ka FDA i ka lehulehu e pili ana nā lāʻau lapaʻau āpau e mālama i ka insomnia i ke kakahiaka aʻe e hoʻokele a me nā hana ʻē aʻe e pono ai ka makaʻala.Ua helu ʻia ka hiamoe ma ke ʻano he hopena maʻamau i nā lepili lāʻau no nā lāʻau insomnia āpau.Hoʻomaopopo ka FDA i nā poʻe maʻi e hiamoe ana lākou i ka lā aʻe ma hope o ka lawe ʻana i kēia mau huahana.Hiki i nā poʻe maʻi e lawe i nā lāʻau insomnia ke ʻike i ka emi ʻana o ka makaʻala noʻonoʻo inā paha lākou e ala loa i ke kakahiaka aʻe ma hope o ka hoʻohana ʻana.
ʻIke hou aku no ka mea maʻi
• Hiki i ka Eszopicone, Zaleplon, Zolpidem ke hana i nā ʻano moe paʻakikī, e like me ka hele wāwae, ka hoʻokele moe, a me nā hana ʻē aʻe me ka ʻole o ka makaʻala.He kakaikahi kēia mau moe moe paʻakikī akā ua hōʻeha nui a make.
• Hiki i kēia mau hanana ke hana me hoʻokahi wale nō o kēia mau lāʻau lapaʻau a i ʻole ma hope o ka lōʻihi o ka mālama ʻana.
• Inā pilikia ka moe hiamoe o ka mea maʻi, e hoʻōki koke i ka lawe ʻana a e ʻimi koke i ka ʻōlelo aʻo kino.
• E lawe i ka lāʻau lapaʻau e like me ke kuhikuhi a kāu kauka.I mea e hōʻemi ai i ka hiki ʻana o nā hanana ʻino, mai overdosage, overdose lāʻau.
Mai lawe i ka eszopiclone, zaleplon a i ʻole zolpidem inā ʻaʻole hiki iā ʻoe ke hōʻoia i ka hiamoe kūpono ma hope o ka lawe ʻana i ka lāʻau lapaʻau.Inā wikiwiki ʻoe ma hope o ka lawe ʻana i ka lāʻau lapaʻau, hiki paha iā ʻoe ke hiamoe a loaʻa nā pilikia me ka hoʻomanaʻo, ka makaʻala a i ʻole ka hoʻonohonoho ʻana.
E hoʻohana i ka eszopiclone, zolpidem (flakes, sustained release tablets, sublingual tablets or oral sprays), pono e moe koke ma hope o ka lawe ʻana i ka lāʻau, a noho ma kahi moe no 7 a 8 mau hola.
E hoʻohana i nā papa zaleplon a i ʻole nā papa haʻahaʻa zolpidem sublingual, pono e lawe ʻia ma kahi moe, a ma kahi o 4 mau hola ma kahi moe.
• I ka lawe ʻana i ka eszopiclone, zaleplon, a me zolpidem, mai hoʻohana i nā lāʻau lapaʻau ʻē aʻe e kōkua iā ʻoe e hiamoe, me kekahi mau lāʻau lapaʻau.Mai inu i ka waiʻona ma mua o ka lawe ʻana i kēia mau lāʻau no ka mea e hoʻonui ai i ka hopena o nā hopena ʻaoʻao a me nā hopena ʻino.
ʻIke hou aku no nā limahana lapaʻau
• Ua hōʻike ʻia ʻo Eszopiclone, Zaleplon, a me Zolpidem i ke kumu o ka moe moe paʻakikī.ʻO ka moe hiamoe paʻakikī e pili ana i ka hana a ka mea maʻi me ka ʻole o ka makaʻala loa, hiki ke alakaʻi i ka ʻeha nui a me ka make.
• Hiki i kēia mau hanana ke hana me hoʻokahi wale nō o kēia mau lāʻau lapaʻau a i ʻole ma hope o ka lōʻihi o ka mālama ʻana.
• ʻAʻole pāpā ʻia ka poʻe maʻi i ʻike mua i ka moe moe paʻakikī me ka eszopiclone, zaleplon, a me zolpidem mai ke kuhikuhi ʻana i kēia mau lāʻau.
• E haʻi aku i nā poʻe maʻi e hoʻōki i ka hoʻohana ʻana i nā lāʻau insomnia inā ua ʻike lākou i nā ʻano moe moe paʻakikī, ʻoiai inā ʻaʻole lākou e hōʻeha nui.
• Ke kuhikuhi ʻana i ka eszopiclone, zaleplon a i ʻole zolpidem i ka mea maʻi, e hahai i nā ʻōlelo aʻoaʻo i loko o nā kuhikuhi, e hoʻomaka me ka haʻahaʻa haʻahaʻa haʻahaʻa.
• Paipai i nā poʻe maʻi e heluhelu i nā alakaʻi lāʻau i ka wā e hoʻohana ai i ka eszopiclone, zaleplon a i ʻole zolpidem, a hoʻomanaʻo iā lākou ʻaʻole e hoʻohana i nā lāʻau insomnia ʻē aʻe, ka waiʻona a i ʻole nā mea hoʻopaneʻe o ke kikowaena.
(pūnaewele FDA)
Ka manawa hoʻouna: ʻAukake-13-2019